May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Effect of TNF-alpha on ARPE-19 Secreted Protein
E. An; J. Lin; K. Csaky; Y. Hathout
Author Affiliations & Notes
  • E. An
    Center for Genetic Medicine, Children's National Medical Center, Washington, Dist. of Columbia
    Biochemistry and Molecular Genetics, The George Washington University, Washington, Dist. of Columbia
  • J. Lin
    Center for Genetic Medicine, Children's National Medical Center, Washington, Dist. of Columbia
  • K. Csaky
    National Eye Institute, National Institutes of Health, Bethesda, Dist. of Columbia
  • Y. Hathout
    Center for Genetic Medicine, Children's National Medical Center, Washington, Dist. of Columbia
  • Footnotes
    Commercial Relationships E. An, None; J. Lin, None; K. Csaky, None; Y. Hathout, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 2198. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Effect of TNF-alpha on ARPE-19 Secreted Protein
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      E. An, J. Lin, K. Csaky, Y. Hathout; Effect of TNF-alpha on ARPE-19 Secreted Protein. Invest. Ophthalmol. Vis. Sci. 2007;48(13):2198.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose:: Tumor necrosis factor-α (TNF-α) is one of the major inflammatory cytokines which is known to be involved in the pathogenesis of various vitreoretinal diseases including age related macular degeneration. To study the effect of cytokines on retinal pigment epithelium cells, we investigated the effect of TNF-α on ARPE19 to test whether RPE protein secretion is altered under inflammatory mediated injury which may help understanding AMD pathology (e.g. drusen formation and choroidal neovascularization).

Methods:: All proteins in ARPE19 cells were metabolically labeled by growing the cells in medium containing 13C6-Arg and 13C6, 15N2-Lys. This strategy will enable us to distinguish RPE secreted proteins from serum protein contaminants. LC-MS/MS analysis and ZoomQuant quantification were used to assess differential protein secretion in TNF-α treated RPE cell versus non-treated cells. Differentially secreted proteins were evaluated by the Ingenuity computational pathway analysis software to identify possible global functions of the secreted protein pattern.

Results:: A total of 58 proteins were identified and quantified in the spent media of TNF-α treated RPE versus non-treated RPE cells. A significant Ingenuity pathway network was obtained for 18 among 21 upregulated proteins in TNF-α treated cell. The most relevant function extracted from this network was related to angiogenesis. For example Plasminogen activator inhibitor 1 precursor which promotes angiogenesis was elevated in TNF-α treated RPE cells by almost a factor of 2 when compared to non treated cells. Other upregulated secreted proteins that have angiogenic activity include pigment epithelium-derived factor, Thrombospondin-1, Laminin alpha-5 chain, Laminin gamma-1 chain and complement C3. While other proteins such as Tolloid-like protein 2, Semaphorin-7A, Vimentin, Glucose-6-phosphate isomerase, Desmoglein-2, Collagen alpha-1(VI) chain, and inter-alpha-trypsin inhibitor heavy chain were down regulated following treatment with TNF-alpha.

Conclusions:: These preliminary data clearly show that RPE cells secret several proteins that are involved in the regulation of angiogenesis. Alteration in the secretion of these proteins may bring insight into understanding choroidal neovascularization seen in some AMD patients.

Keywords: proteomics • retinal pigment epithelium • stress response 
© 2007, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept